By James Davey and Helen Reid LONDON (Reuters) – Supermarkets in the UK and Europe are offering more own-brand festive food from roast duck to truffle crackers as cash-strapped families spend on Christmas meals at home while cutting down on […]
Festive food and fizz top Europeans’ Christmas shopping list Read More »
By Wayne Cole SYDNEY (Reuters) -Asia stocks slipped on Monday in a subdued start to a week where Japan’s central bank might edge further away from its uber-easy policies, while a key reading on U.S. inflation is expected to underpin
Asia shares subdued for BOJ meeting, US inflation test Read More »
By Ebru Tuncay and Alexander Cornwell ISTANBUL (Reuters) -Abu Dhabi is set to buy a stake in a key Turkish port, according to four sources aware of the deal, in a further sign of a rapprochement between the once bitter
Abu Dhabi nears deal to buy stake in Turkish port -sources Read More »
By Florence Tan and Emily Chow SINGAPORE (Reuters) -Oil prices rose in Asian trade on Monday, rising nearly 1% in early trade, supported by lower exports from Russia and as attacks by the Houthis on ships in the Red Sea
Oil climbs on drop in Russia exports, Red Sea jitters Read More »
(This Dec. 15 story has been corrected to fix the name of the reporter in the signoff line at the end of story) By Carolina Mandl and Summer Zhen NEW YORK/HONG KONG (Reuters) – Global equities long/short hedge funds’ bets
Hedge funds’ bearish bets get crushed in post-Fed meeting rally Read More »
(This Dec. 15 story has been corrected to fix the name of the reporter in the signoff line at the end of story) By Carolina Mandl and Summer Zhen NEW YORK/HONG KONG (Reuters) – Global equities long/short hedge funds’ bets
Hedge funds’ bearish bets get crushed in post-Fed meeting rally Read More »
(Reuters) – Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European antitrust enforcers for more than two years and faced fierce opposition from activist investor Carl
Illumina to divest cancer test maker Grail after antitrust battles Read More »
(Corrects to say Icahn ‘did not’ immediately respond to Reuters request for comment in paragraph 15) (Reuters) -Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European
Illumina to divest cancer test maker Grail after antitrust battles Read More »
BEIJING (Reuters) -China’s economy is expected to see more favourable conditions and more opportunities than challenges in 2024, state media said citing officials of the Chinese Communist Party’s finance and economy office. Macroeconomic policies will continue to provide support for
China’s economic conditions to improve in 2024 – officials Read More »
(Reuters) – Citigroup Inc’s plan to set up a wholly-owned securities business in China is taking longer than expected because the bank needs more time to comply with the country’s data laws, Bloomberg News reported on Monday. The bank is
Citigroup China investment bank plans delayed by data law -Bloomberg News Read More »
